Skip to main content

The RNA editing enzymes ADARs: mechanism of action and human disease

Abstract

A-to-I RNA editing is a ubiquitous and crucial molecular mechanism able to convert adenosines into inosines (then read as guanosines by several intracellular proteins/enzymes) within RNA molecules, changing the genomic information. The A-to-I deaminase enzymes (ADARs), which modify the adenosine, can alter the splicing and translation machineries, the double-stranded RNA structures and the binding affinity between RNA and RNA-binding proteins. ADAR activity is an essential mechanism in mammals and altered editing has been associated with several human diseases. Many efforts are now being concentrated on modifying ADAR activity in vivo in an attempt to correct RNA editing dysfunction. Concomitantly, ongoing studies aim to show the way that the ADAR deaminase domain can be used as a possible new tool, an intracellular Trojan horse, for the correction of heritage diseases not related to RNA editing events.

This is a preview of subscription content, access via your institution.

References

  • Aizawa H, Sawada J, Hideyama T, Yamashita T, Katayama T, Hasebe N, Kimura T, Yahara O, Kwak S (2010) TDP-43 pathology in sporadic ALS occurs in motor neurons lacking the RNA editing enzyme ADAR2. Acta Neuropathol 120:75–84

    CAS  PubMed  Article  Google Scholar 

  • Alon S, Mor E, Vigneault F, Church GM, Locatelli F, Galeano F, Gallo A, Shomron N, Eisenberg E (2012) Systematic identification of edited microRNAs in the human brain. Genome Res 22:1533–1540

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  • Athanasiadis A, Rich A, Maas S (2004) Widespread A-to-I RNA editing of Alu-containing mRNAs in the human transcriptome. PLoS Biol 2:2144–2158

    CAS  Article  Google Scholar 

  • Bass BL (2006) How does RNA editing affect dsRNA-mediated gene silencing? Cold Spring Harb Symp Quant Biol 71:285–292

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  • Cenci C, Barzotti R, Galeano F, Corbelli S, Rota R, Massimi L, Di Rocco C, O'Connell MA, Gallo A (2008) Down-regulation of RNA editing in pediatric astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation. J Biol Chem 283:7251–7260

    CAS  PubMed  Article  Google Scholar 

  • Chan TH, Lin CH, Qi L, Fei J, Li Y, Yong KJ, Liu M, Song Y, Chow RK, Ng VH, Yuan YF, Tenen DG, Guan XY, Chen L (2013) A disrupted RNA editing balance mediated by ADARs (adenosine deaminases that act on RNA) in human hepatocellular carcinoma. Gut. doi:10.1136/gutjnl-2012-304037

    Google Scholar 

  • Chen L, Li Y, Lin CH, Chan TH, Chow RK, Song Y, Liu M, Yuan YF, Fu L, Kong KL, Qi L, Li Y, Zhang N, Tong AH, Kwong DL, Man K, Lo CM, Lok S, Tenen DG, Guan XY (2013) Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma. Nat Med 19:209–216

    PubMed Central  PubMed  Article  Google Scholar 

  • Choudhury Y, Tay FC, Lam DH, Sandanaraj E, Tang C, Ang BT, Wang S (2012) Attenuated adenosine-to-inosine editing of microRNA-376a* promotes invasiveness of glioblastoma cells. J Clin Invest 122:4059–4076

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  • Galeano F, Rossetti C, Tomaselli S, Cifaldi L, Lezzerini M, Pezzullo M, Boldrini R, Massimi L, Di Rocco CM, Locatelli F, Gallo A (2012a) ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis. Oncogene 32:998–1009

    PubMed Central  PubMed  Article  Google Scholar 

  • Galeano F, Tomaselli S, Locatelli F, Gallo A (2012b) A-to-I RNA editing: the “ADAR” side of human cancer. Semin Cell Dev Biol 23:244–250

    CAS  PubMed  Article  Google Scholar 

  • Gallo A, Locatelli F (2011) ADARs: allies or enemies? The importance of A-to-I RNA editing in human disease: from cancer to HIV-1. Biol Rev Camb Philos Soc 87:95–110

    PubMed  Article  Google Scholar 

  • Gott JM, Emeson RB (2000) Functions and mechanisms of RNA editing. Annu Rev Genet 34:499–531

    CAS  PubMed  Article  Google Scholar 

  • Greger IH, Khatri L, Ziff EB (2002) RNA editing at arg607 controls AMPA receptor exit from the endoplasmic reticulum. Neuron 34:759–772

    CAS  PubMed  Article  Google Scholar 

  • Greger IH, Khatri L, Kong X, Ziff EB (2003) AMPA receptor tetramerization is mediated by Q/R editing. Neuron 40:763–774

    CAS  PubMed  Article  Google Scholar 

  • Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, Cooch N, Shiekhattar R (2004) The microprocessor complex mediates the genesis of microRNAs. Nature 432:235–240

    CAS  PubMed  Article  Google Scholar 

  • Hartner JC, Schmittwolf C, Kispert A, Muller AM, Higuchi M, Seeburg PH (2004) Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1. J Biol Chem 279:4894–4902

    CAS  PubMed  Article  Google Scholar 

  • Hartner JC, Walkley CR, Lu J, Orkin SH (2009) ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling. Nat Immunol 10:109–115

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  • Heale BS, Keegan LP, McGurk L, Michlewski G, Brindle J, Stanton CM, Caceres JF, O'Connell MA (2009) Editing independent effects of ADARs on the miRNA/siRNA pathways. EMBO J 28:3145–3156

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  • Heale BS, Keegan LP, O'Connell MA (2010) The effect of RNA editing and ADARs on miRNA biogenesis and function. Adv Exp Med Biol 700:76–84

    CAS  PubMed  Article  Google Scholar 

  • Hideyama T, Yamashita T, Suzuki T, Tsuji S, Higuchi M, Seeburg PH, Takahashi R, Misawa H, Kwak S (2010) Induced loss of ADAR2 engenders slow death of motor neurons from Q/R site-unedited GluR2. J Neurosci 30:11917–11925

    CAS  PubMed  Article  Google Scholar 

  • Higuchi M, Maas S, Single FN, Hartner J, Rozov A, Burnashev N, Feldmeyer D, Sprengel R, Seeburg PH (2000) Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature 406:78–81

    CAS  PubMed  Article  Google Scholar 

  • Ishiuchi S, Tsuzuki K, Yoshida Y, Yamada N, Hagimura N, Okado H, Miwa A, Kurihara H, Nakazato Y, Tamura M, Sasaki T, Ozawa S (2002) Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells. Nat Med 8:971–978

    CAS  PubMed  Article  Google Scholar 

  • Kawahara Y, Ito K, Sun H, Aizawa H, Kanazawa I, Kwak S (2004) Glutamate receptors: RNA editing and death of motor neurons. Nature 427:801

    CAS  PubMed  Article  Google Scholar 

  • Kawahara Y, Zinshteyn B, Chendrimada TP, Shiekhattar R, Nishikura K (2007a) RNA editing of the microRNA-151 precursor blocks cleavage by the Dicer-TRBP complex. EMBO Rep 8:763–769

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  • Kawahara Y, Zinshteyn B, Sethupathy P, Iizasa H, Hatzigeorgiou AG, Nishikura K (2007b) Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science 315:1137–1140

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  • Kawahara Y, Megraw M, Kreider E, Iizasa H, Valente L, Hatzigeorgiou AG, Nishikura K (2008) Frequency and fate of microRNA editing in human brain. Nucleic Acids Res 36:5270–5280

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  • Klaue Y, Kallman AM, Bonin M, Nellen W, Ohman M (2003) Biochemical analysis and scanning force microscopy reveal productive and nonproductive ADAR2 binding to RNA substrates. RNA 9:839–846

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  • Kwak S, Hideyama T, Yamashita T, Aizawa H (2010) AMPA receptor-mediated neuronal death in sporadic ALS. Neuropathology 30:182–188

    PubMed  Article  Google Scholar 

  • Levanon EY, Eisenberg E, Yelin R, Nemzer S, Hallegger M, Shemesh R, Fligelman ZY, Shoshan A, Pollock SR, Sztybel D, Olshansky M, Rechavi G, Jantsch MF (2004) Systematic identification of abundant A-to-I editing sites in the human transcriptome. Nat Biotechnol 22:1001–1005

    CAS  PubMed  Article  Google Scholar 

  • Lev-Maor G, Sorek R, Levanon EY, Paz N, Eisenberg E, Ast G (2007) RNA-editing-mediated exon evolution. Genome Biol 8:R29

    PubMed Central  PubMed  Article  Google Scholar 

  • Maas S, Patt S, Schrey M, Rich A (2001) Underediting of glutamate receptor GluR-B mRNA in malignant gliomas. Proc Natl Acad Sci U S A 98:14687–14692

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  • Maas S, Kawahara Y, Tamburro KM, Nishikura K (2006) A-to-I RNA editing and human disease. RNA Biol 3:1–9

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  • Maison C, Bailly D, Peters AH, Quivy JP, Roche D, Taddei A, Lachner M, Jenuwein T, Almouzni G (2002) Higher-order structure in pericentric heterochromatin involves a distinct pattern of histone modification and an RNA component. Nat Genet 30:329–334

    PubMed  Article  Google Scholar 

  • Moller-Krull M, Zemann A, Roos C, Brosius J, Schmitz J (2008) Beyond DNA: RNA editing and steps toward Alu exonization in primates. J Mol Biol 382:601–609

    PubMed  Article  Google Scholar 

  • Montiel-Gonzalez MF, Vallecillo-Viejo I, Yudowski GA, Rosenthal JJ (2013) Correction of mutations within the cystic fibrosis transmembrane conductance regulator by site-directed RNA editing. Proc Natl Acad Sci U S A 110:18285–18290

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  • Muchardt C, Guilleme M, Seeler JS, Trouche D, Dejean A, Yaniv M (2002) Coordinated methyl and RNA binding is required for heterochromatin localization of mammalian HP1alpha. EMBO Rep 3:975–981

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  • Nishikura K (2006) Editor meets silencer: crosstalk between RNA editing and RNA interference. Nat Rev Mol Cell Biol 7:919–931

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  • Nishikura K (2010) Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem 79:321–349

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  • Ota H, Sakurai M, Gupta R, Valente L, Wulff BE, Ariyoshi K, Iizasa H, Davuluri RV, Nishikura K (2013) ADAR1 forms a complex with Dicer to promote microRNA processing and RNA-induced gene silencing. Cell 153:575–589

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  • Paz N, Levanon EY, Amariglio N, Heimberger AB, Ram Z, Constantini S, Barbash ZS, Adamsky K, Safran M, Hirschberg A, Krupsky M, Ben-Dov I, Cazacu S, Mikkelsen T, Brodie C, Eisenberg E, Rechavi G (2007) Altered adenosine-to-inosine RNA editing in human cancer. Genome Res 17:1586–1595

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  • Pinto Y, Cohen HY, Levanon EY (2014) Mammalian conserved ADAR targets comprise only a small fragment of the human editosome. Genome Biol 15:R5

    PubMed  Article  Google Scholar 

  • Qin YR, Qiao JJ, Chan TH, Zhu YH, Li FF, Liu H, Fei J, Li Y, Guan XY, Chen L (2014) Adenosine-to-inosine RNA editing mediated by ADARs in esophageal squamous cell carcinoma. Cancer Res 74:840–851

    CAS  PubMed  Article  Google Scholar 

  • Ramaswami G, Li JB (2014) RADAR: a rigorously annotated database of A-to-I RNA editing. Nucleic Acids Res 42:D109–D113

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  • Ramaswami G, Lin W, Piskol R, Tan MH, Davis C, Li JB (2012) Accurate identification of human Alu and non-Alu RNA editing sites. Nat Methods 9:579–581

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  • Ramaswami G, Zhang R, Piskol R, Keegan LP, Deng P, O'Connell MA, Li JB (2013) Identifying RNA editing sites using RNA sequencing data alone. Nat Methods 10:128–132

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  • Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, Rahmani Z, Krizus A, McKenna-Yasek D, Cayabyab A, Gaston SM, Berger R, Tanzi RE, Halperin JJ, Herzfeldt B, Van den Bergh R, Hung W-Y, Bird T, Deng G, Mulder DW, Smyth C, Laing NG, Soriano E, Pericak–Vance MA, Haines J, Rouleau GA, Gusella JS, Horvitz HR, Brown RH Jr (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59–62

    CAS  PubMed  Article  Google Scholar 

  • Savva YA, Jepson JE, Chang YJ, Whitaker R, Jones BC, St Laurent G, Tackett MR, Kapranov P, Jiang N, Du G, Helfand SL, Reenan RA (2013) RNA editing regulates transposon-mediated heterochromatic gene silencing. Nat Commun 4:2745

    PubMed Central  PubMed  Article  Google Scholar 

  • Scadden AD (2005) The RISC subunit Tudor-SN binds to hyper-edited double-stranded RNA and promotes its cleavage. Nat Struct Mol Biol 12:489–496

    CAS  PubMed  Article  Google Scholar 

  • Schirle NT, Goodman RA, Krishnamurthy M, Beal PA (2010) Selective inhibition of ADAR2-catalyzed editing of the serotonin 2c receptor pre-mRNA by a helix-threading peptide. Org Biomol Chem 8:4898–4904

    CAS  PubMed  Article  Google Scholar 

  • Seeburg PH, Higuchi M, Sprengel R (1998) RNA editing of brain glutamate receptor channels: mechanism and physiology. Brain Res Brain Res Rev 26:217–229

    CAS  PubMed  Article  Google Scholar 

  • Sommer B, Kohler M, Sprengel R, Seeburg PH (1991) RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell 67:11–19

    CAS  PubMed  Article  Google Scholar 

  • Tomaselli S, Bonamassa B, Alisi A, Nobili V, Locatelli F, Gallo A (2013) ADAR enzyme and miRNA story: a nucleotide that can make the difference. Int J Mol Sci 14:22796–22816

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  • Wang Q, Carmichael GG (2004) Effects of length and location on the cellular response to double-stranded RNA. Microbiol Mol Biol Rev 68:432–452

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  • Wang Q, Khillan J, Gadue P, Nishikura K (2000) Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis. Science 290:1765–1768

    CAS  PubMed  Article  Google Scholar 

  • Wang Q, Miyakoda M, Yang W, Khillan J, Stachura DL, Weiss MJ, Nishikura K (2004) Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene. J Biol Chem 279:4952–4961

    CAS  PubMed  Article  Google Scholar 

  • Wang Q, Zhang Z, Blackwell K, Carmichael GG (2005) Vigilins bind to promiscuously A-to-I-edited RNAs and are involved in the formation of heterochromatin. Curr Biol 15:384–391

    CAS  PubMed  Article  Google Scholar 

  • XuFeng R, Boyer MJ, Shen H, Li Y, Yu H, Gao Y, Yang Q, Wang Q, Cheng T (2009) ADAR1 is required for hematopoietic progenitor cell survival via RNA editing. Proc Natl Acad Sci U S A 106:17763–17768

    PubMed Central  PubMed  Article  Google Scholar 

  • Yamashita T, Chai HL, Teramoto S, Tsuji S, Shimazaki K, Muramatsu S, Kwak S (2013) Rescue of amyotrophic lateral sclerosis phenotype in a mouse model by intravenous AAV9-ADAR2 delivery to motor neurons. EMBO Mol Med 5:1710–1719

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  • Yang W, Chendrimada TP, Wang Q, Higuchi M, Seeburg PH, Shiekhattar R, Nishikura K (2006) Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nat Struct Mol Biol 13:13–21

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  • Yates LA, Norbury CJ, Gilbert RJ (2013) The long and short of microRNA. Cell 153:516–519

    CAS  PubMed  Article  Google Scholar 

  • Zhang Z, Carmichael GG (2001) The fate of dsRNA in the nucleus: a p54(nrb)-containing complex mediates the nuclear retention of promiscuously A-to-I edited RNAs. Cell 106:465–475

    CAS  PubMed  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Angela Gallo.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Tomaselli, S., Locatelli, F. & Gallo, A. The RNA editing enzymes ADARs: mechanism of action and human disease. Cell Tissue Res 356, 527–532 (2014). https://doi.org/10.1007/s00441-014-1863-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00441-014-1863-3

Keywords

  • RNA editing
  • ADARs
  • Inosine
  • Heterochromatin
  • Human diseases